首页> 外文期刊>Current hypertension reports. >Pheochromocytoma: diagnosis and management update.
【24h】

Pheochromocytoma: diagnosis and management update.

机译:嗜铬细胞瘤:诊断和管理更新。

获取原文
获取原文并翻译 | 示例
           

摘要

Pheochromocytoma is a rare but extremely treacherous neuroendocrine tumor causing manifestations by secreting catecholamines into the circulation. It is usually fatal if unrecognized. Manifestations can mimic many diseases and cause erroneous diagnoses. Approximately 15% are malignant, 18% extra-adrenal, and 20% familial. Plasma or urinary metanephrines are approximately 98% sensitive for detecting pheochromocytomas. They can be localized by MRI and CT; (131)I- and (123)I-metaiodobenzylguanidine (MIBG) are highly specific and 81% to 90% sensitive, respectively. Suspect pheochromocytoma in patients with sustained or paroxysmal hypertension or in normotensives having manifestations of hypercatecholaminemia. Surgical removal is usually curative; chemotherapy and radiotherapy are palliative for malignant pheochromocytomas.
机译:嗜铬细胞瘤是一种罕见但极度诡异的神经内分泌肿瘤,通过将儿茶酚胺分泌到循环中而引起表现。如果无法识别,通常会致命。表现形式可能会模仿许多疾病并导致错误的诊断。大约15%为恶性,18%肾上腺外和20%家族性。血浆或尿中的肾上腺素对检测嗜铬细胞瘤敏感度约为98%。它们可以通过MRI和CT定位; (131)I-和(123)I-甲氧苄基胍(MIBG)分别具有高特异性和81%至90%的敏感性。患有持续性或阵发性高血压或具有高儿茶酚胺症表现的血压正常者的可疑嗜铬细胞瘤。手术切除通常可以治愈;化学疗法和放射疗法可缓解恶性嗜铬细胞瘤。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号